(Q42986628)

12 November 2017

title

Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas (English)

1 reference

12 November 2017

1 reference

1 reference

Kelaidi C

1

1 reference

12 November 2017

Rollot F

2

1 reference

12 November 2017

Park S

3

1 reference

12 November 2017

Tulliez M

4

1 reference

12 November 2017

Christoforov B

5

1 reference

12 November 2017

Calmus Y

6

1 reference

12 November 2017

Podevin P

7

1 reference

12 November 2017

Bouscary D

8

1 reference

12 November 2017

Sogni P

9

1 reference

12 November 2017

Blanche P

10

1 reference

12 November 2017

Dreyfus F

11

1 reference

12 November 2017

publication date

1 October 2004

1 reference

12 November 2017

number of pages

6

1 reference

inferred from page(s)

published in

Leukemia

1 reference

12 November 2017

volume

18

1 reference

12 November 2017

issue

10

1 reference

12 November 2017

page(s)

1711-1716

1 reference

Hepatitis C virus infection in patients with non-Hodgkin's lymphoma

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

Additional neoplasms and HCV infection in low-grade lymphoma of MALT type

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

Hepatitis C virus and non-Hodgkin's lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

Hepatitis C virus infection in non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

No association between hepatitis C and B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

The role of hepatitis C virus in the aetiology of non-Hodgkins lymphoma--a regional association?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

HCV and HGV in B-cell non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1,576 patients in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

Prospective study of hepatitis C viral infection as a risk factor for subsequent B-cell neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

Extrahepatic manifestations of hepatitis C among United States male veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

bcl-2 and immunoglobulin gene rearrangement in patients with hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

V(H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

Immunoglobulin Gene Mutations and Frequent Use of VH1-69 and VH4-34 Segments in Hepatitis C Virus-Positive and Hepatitis C Virus-Negative Nodal Marginal Zone B-Cell Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

Pre-malignant and malignant lymphoproliferations in an HCV-infected type II mixed cryoglobulinemic patient are sequential phases of an antigen-driven pathological process

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

Binding of hepatitis C virus to CD81

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

Activation of STAT3 by the Hepatitis C Virus Core Protein Leads to Cellular Transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type II cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

Treatment of HCV-related mantle-cell lymphoma with ribavirin and pegylated interferon Alfa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

Hepatitis C virus genotype distribution in B-cell non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

Genetic abnormalities in marginal zone B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

Systematic screening for HCV infection should be performed in patients with splenic marginal zone lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

7 January 2021

Rapid, multifluorescent TCRG Vgamma and Jgamma typing: application to T cell acute lymphoblastic leukemia and to the detection of minor clonal populations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

7 January 2021

Distinct chromosome 3 abnormalities in persistent polyclonal B-cell lymphocytosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

7 January 2021

Persistent polyclonal B lymphocytosis: an expansion of cells showing IgVH gene mutations and phenotypic features of normal lymphocytes from the CD27+ marginal zone B-cell compartment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

7 January 2021

Antigen-driven clonal T cell expansion in disorders of hematopoiesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

7 January 2021

Immunological studies of gamma delta T cells in a case of large granular lymphocyte (LGL) leukemia: leukemic gamma delta+ T cells are resistant to growth stimulation in vitro but respond to interferon-alpha treatment in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403443

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2403443

1 reference

Dimensions Publication ID

12 November 2017

1007007214

0 references

1 reference